Why is Mankind Pharma falling/rising?

As of 31-Jul, Mankind Pharma Ltd's stock price is currently at 2,552.90, reflecting a decrease of 9.6 points or 0.37%. The stock has shown a trend reversal, falling after two consecutive days of gains, and opened with a loss of 2% today, reaching an intraday low of Rs 2511.35. Despite this decline, the stock has outperformed its sector by 1.12% today. Over the past month, Mankind Pharma has demonstrated strong performance with an increase of 11.54%, while year-to-date it has seen a decline of 11.26%. The company benefits from high management efficiency, a low Debt to EBITDA ratio, and strong institutional holdings, which contribute positively to its fundamentals and may support its price despite recent volatility. In the broader market context, Mankind Pharma's short-term performance has been slightly worse than the benchmark, with a 1-week return of -1.43% compared to the Sensex's -1.22%. However, the stock has significantly outperformed the market over the past year, generating a return of 25.69% while the broader market (BSE500) has seen a decline of 3.20%. This indicates that while the stock is currently experiencing a dip, its long-term growth prospects remain strong, supported by healthy operating profit growth and rising investor participation, which may help stabilize its price in the future.